Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiology | 3 | 2015 | 1656 | 0.660 |
Why?
|
| Heart Failure | 7 | 2023 | 11669 | 0.610 |
Why?
|
| Early Ambulation | 1 | 2018 | 49 | 0.600 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2023 | 628 | 0.580 |
Why?
|
| Patient Readmission | 3 | 2018 | 3270 | 0.570 |
Why?
|
| Heart-Assist Devices | 1 | 2023 | 1287 | 0.410 |
Why?
|
| Patient Care Management | 1 | 2014 | 302 | 0.370 |
Why?
|
| Pleural Effusion | 1 | 2014 | 341 | 0.370 |
Why?
|
| Workload | 1 | 2015 | 844 | 0.340 |
Why?
|
| Medicine | 1 | 2014 | 942 | 0.260 |
Why?
|
| Fellowships and Scholarships | 1 | 2014 | 1117 | 0.260 |
Why?
|
| Drug-Eluting Stents | 1 | 2012 | 681 | 0.250 |
Why?
|
| Liver Diseases | 1 | 2014 | 1298 | 0.250 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2220 | 0.250 |
Why?
|
| Terminology as Topic | 1 | 2012 | 1530 | 0.230 |
Why?
|
| Length of Stay | 1 | 2018 | 6425 | 0.230 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2373 | 0.200 |
Why?
|
| Aortic Valve Stenosis | 1 | 2014 | 2001 | 0.190 |
Why?
|
| Echocardiography | 1 | 2014 | 4989 | 0.190 |
Why?
|
| Radiology | 1 | 2014 | 2113 | 0.170 |
Why?
|
| Hemorrhage | 1 | 2012 | 3424 | 0.170 |
Why?
|
| Models, Statistical | 1 | 2014 | 5079 | 0.170 |
Why?
|
| Cardiovascular Agents | 2 | 2015 | 840 | 0.150 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 5127 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 6403 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 8002 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2014 | 23995 | 0.130 |
Why?
|
| Myocarditis | 1 | 2023 | 788 | 0.130 |
Why?
|
| Quality Improvement | 3 | 2015 | 3801 | 0.120 |
Why?
|
| Fee-for-Service Plans | 1 | 2018 | 700 | 0.110 |
Why?
|
| Community Mental Health Services | 1 | 2015 | 392 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2023 | 1462 | 0.100 |
Why?
|
| Incidental Findings | 1 | 2014 | 697 | 0.080 |
Why?
|
| Logistic Models | 2 | 2015 | 13255 | 0.080 |
Why?
|
| Endpoint Determination | 1 | 2012 | 590 | 0.080 |
Why?
|
| Career Choice | 1 | 2014 | 756 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 1403 | 0.070 |
Why?
|
| Shock, Cardiogenic | 2 | 2023 | 709 | 0.070 |
Why?
|
| Myocardial Infarction | 2 | 2022 | 11460 | 0.070 |
Why?
|
| Continuity of Patient Care | 1 | 2014 | 1069 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 20098 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3416 | 0.060 |
Why?
|
| Disabled Persons | 1 | 2015 | 1225 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 2169 | 0.060 |
Why?
|
| Indazoles | 1 | 2007 | 304 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2018 | 3443 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2012 | 2115 | 0.060 |
Why?
|
| Sirolimus | 1 | 2012 | 1533 | 0.060 |
Why?
|
| Registries | 2 | 2023 | 8224 | 0.060 |
Why?
|
| Survivors | 1 | 2015 | 2371 | 0.060 |
Why?
|
| Risk Factors | 4 | 2023 | 74206 | 0.060 |
Why?
|
| Humans | 11 | 2023 | 761504 | 0.050 |
Why?
|
| Capillary Permeability | 1 | 2007 | 773 | 0.050 |
Why?
|
| Aged | 4 | 2018 | 169289 | 0.050 |
Why?
|
| Massachusetts | 1 | 2014 | 8830 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6484 | 0.050 |
Why?
|
| Imidazoles | 1 | 2007 | 1180 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 7827 | 0.040 |
Why?
|
| Male | 6 | 2023 | 360804 | 0.040 |
Why?
|
| Comorbidity | 1 | 2014 | 10508 | 0.040 |
Why?
|
| Female | 7 | 2023 | 392644 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14666 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7390 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12059 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10723 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 12463 | 0.040 |
Why?
|
| Telemedicine | 1 | 2014 | 3051 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15500 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 2645 | 0.030 |
Why?
|
| Incidence | 1 | 2014 | 21353 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39106 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 58976 | 0.030 |
Why?
|
| Health Plan Implementation | 1 | 2015 | 337 | 0.030 |
Why?
|
| Middle Aged | 2 | 2018 | 220895 | 0.020 |
Why?
|
| United States | 2 | 2015 | 72334 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 39967 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 54425 | 0.020 |
Why?
|
| Violence | 1 | 2015 | 936 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2022 | 5294 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2012 | 64680 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2007 | 535 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2007 | 664 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2007 | 3615 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 21012 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 36426 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 80636 | 0.010 |
Why?
|
| Contrast Media | 1 | 2007 | 5311 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 10445 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 221177 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 13639 | 0.000 |
Why?
|
| Mice | 1 | 2007 | 81525 | 0.000 |
Why?
|
| Animals | 1 | 2007 | 168459 | 0.000 |
Why?
|
Concepts
(92)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_